WO2004014408A1 - 膣内洗浄剤 - Google Patents
膣内洗浄剤 Download PDFInfo
- Publication number
- WO2004014408A1 WO2004014408A1 PCT/JP2003/009989 JP0309989W WO2004014408A1 WO 2004014408 A1 WO2004014408 A1 WO 2004014408A1 JP 0309989 W JP0309989 W JP 0309989W WO 2004014408 A1 WO2004014408 A1 WO 2004014408A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- soymilk
- extract
- vaginal
- cleaning agent
- lactic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Definitions
- the present invention relates to a cleaning agent for washing the inside of a vagina affected by vaginal infections such as bacterial vaginosis, Chlamydia vaginitis, Trichomonas vaginitis, Candida vaginitis, and is also effective as a therapeutic agent. It relates to medical and pharmaceutical technology. Background art
- lactobacilli In the vagina of healthy adult women after menarche, for example, there are many bacteria belonging to the genus Lactobacillus such as Bacillus derdeline, and the presence of these lactobacilli causes a normal bacterial balance in the vagina. It is maintained and genital infection by pathogenic microorganisms is prevented. These lactobacilli propagate by using glycogen secreted from the vaginal mucosa as an energy source, compete with pathogens from behind, and protect the vaginal cavity from attack by other bacteria. With the development of a large number of antibiotics in the United States, as antibiotic preparations are frequently used, lactobacilli present in the vagina have been controlled.
- lactic acid bacteria fermentation broth extract which is presumed to have the effect of improving the state of intestinal microorganisms and is commercially available or produced by lactic acid bacteria. It solves the problem and is an excellent vagina cleansing agent for women suffering from bacterial vaginosis, Chlamydia vasculitis, Trichomonas vaginitis, Candida vaginitis, etc.
- the present invention was completed by finding that it is effective as a therapeutic agent.
- It consists of a soymilk fermentation solution obtained by fermenting soymilk by co-culturing multiple lactic acid bacteria.
- It consists of an extract obtained by sterilizing soymilk fermentation broth obtained by fermenting soymilk by co-culturing of multiple lactic acid bacteria, adding alcohol, and extracting with alcohol over a period of six months or more.
- It consists of an extract obtained by alcohol extraction of a soymilk fermentation broth obtained by fermenting soymilk by co-culturing a plurality of lactic acid bacteria,
- the extract should contain a total of 20% or more of components whose retention time by liquid chromatography measured under the following conditions is 10 minutes or more.
- vaginal cleaning agent characterized by.
- It consists of an extract obtained by alcohol extraction of a soymilk fermentation broth obtained by fermenting soymilk by co-culturing a plurality of lactic acid bacteria,
- the extract should contain a total of 25% or more of components whose retention time by liquid chromatography measured under the following conditions is 7 minutes or more.
- vaginal cleaning agent characterized by.
- the invention according to claim 6 of the present invention is It consists of an extract obtained by alcohol extraction of a soymilk fermentation broth obtained by fermenting soymilk by co-culturing a plurality of lactic acid bacteria,
- the extract should contain a total of 25% or more of components with a retention time of 7 minutes or more and 20% or more of components with a retention time of 10 minutes or more measured by the liquid chromatograph measured under the following conditions.
- vaginal cleaning agent characterized by.
- FIG. 1 shows the liquid chromate of the lactic acid bacteria fermentation broth extract in this invention.
- An intravaginal cleaning agent comprises a soymilk fermentation solution as an active ingredient, and the soymilk fermentation solution is obtained by co-culture of a plurality of lactic acid bacteria, soymilk It is a soymilk fermented liquid obtained by fermenting sucrose, preferably a soymilk fermented liquid obtained by culturing for about 100 hours to 300 hours. More specifically, those containing various interstitial substances in addition to the soymilk fermented liquid extract, or solids and liquids obtained by solid-liquid separation, including the soymilk fermented liquid extract, may be mentioned. In order to effectively use the extract, the extract extracted with the organic solvent Minutes are preferred.
- an extract obtained by alcohol extraction of a soymilk fermented liquid obtained by fermenting soymilk by co-cultivation of a plurality of lactic acid bacteria is used as a component.
- substances that are estimated to be produced or secreted by lactic acid bacteria hereinafter referred to as “fermented soymilk extract” present in soymilk fermentation broth obtained by fermentation by co-culturing have excellent effects on human health.
- the soymilk fermentation broth extract according to the present invention is obtained from a soymilk fermentation broth fermented with soymilk by co-culturing with a plurality of lactic acid bacteria, in particular, obtained by alcohol extraction from the soymilk fermented liquor.
- alcohol Since alcohol is considered to be a food, it is desirable to use ethanol, and an equivalent amount is added to the soymilk fermentation broth and extracted.
- the fermented soymilk used for the extraction is sterilized, and as a sterilization method, a method such as heat sterilization and cell destruction sterilization is employed.
- the conditions are as follows.
- the extraction can be performed under heating, but is preferably performed at room temperature in order to avoid alteration due to heat, and is preferably performed in a cool and dark place in order to avoid the influence of light over a long period of time. If this extraction is carried out at room temperature, the extraction speed is expected to be slow, but in order to obtain an excellent extract from the soymilk fermentation broth, it takes over a long period of more than six months, preferably more than one year. It is preferable to carry out the process, and an excellent soybean milk fermentation broth extract can be obtained by taking such a long time.
- a soymilk fermentation broth extract having a total of 20% or more, preferably 25% or more of components having a retention time of 10 minutes or more measured under the above conditions is obtained.
- the types of ingredients also increase.
- the soymilk fermented liquid or extract thereof which is an intravaginal cleaning agent of the present invention, is applied as it is or diluted and applied to the vulva, or it is soaked in gauze or the like and pasted on the affected area. Furthermore, the vaginal wall can be cleaned by spraying and spraying the inside of the vagina with a spot and inserting a cotton ball or tampon for a while.
- the soymilk fermentation broth or extract thereof of the present invention is widely ingested as a health maintenance food, has no side effects, is not subject to strict restrictions on the amount applied, and can be used freely.
- the vaginal cleanser of this invention can be used every day, every other day, or every few days, which cleans the inside of the vagina and alleviates symptoms such as bacterial vaginosis, Chlamydia vasculitis, Trichomonas vaginitis, Candida vaginitis Or disappear.
- Each group of lactic acid bacteria was cultured separately for 48 hours while gradually raising the temperature from 20 ° C to 40 ° C using soymilk as a culture medium.
- the cells were transferred to one container and further cultivated for 96 hours while gradually raising the temperature from 20 ° C to 40 ° C.
- the bean fermentation broth obtained after completion of the cultivation was heat sterilized, and then an equal amount of alcohol was added, and the extract was stored for 1 year in a cool and dark place.
- the fermentation liquid obtained above is obtained.
- the lcc was sprayed evenly on the vagina wall with a dropper while looking directly into the vagina, and then a high-pressure sterilized cotton ball was inserted, and then removed 4 hours later.
- vaginal discharge was collected from the vagina, Chlamydia, Trichomonas and Candida were tested. Some of the secretions were clinically diagnosed as bacterial vaginosis. The breakdown of the above 7 was 5 bacterial vaginosis, 1 Chlamydia vasculitis, 1 Candida vaginitis. The cleaning effects in each patient were as follows. The test period was from March to April 2002.
- VAS V i s u a l l a l og S c a l e
- soymilk fermented liquid obtained by fermenting soymilk by co-cultivation with multiple lactic acid bacteria has been identified to some extent, including nucleic acids, amino acids, vitamins Although it is listed as a component, it can be said that it is in an unknown state.
- the function of soymilk fermented juice extract improves the state of intestinal microorganisms, such as hormone synthesis, vitamin and enzyme synthesis, cholesterol metabolism, blood glucose level regulation, blood pressure regulation, etc. It is known to have a variety of effects, such as hepatitis, chronic arthritis, atopic dermatitis, angina pectoris, and anticancer activity against various cancers.
- the soymilk fermented liquid or extract thereof which is an intravaginal cleaning agent of the present invention, is resistant to bacterial vaginosis, chlamydia vasculitis and candidiasis. It is an effective drug (detergent) for da vaginitis, and its strength is fast-acting and showed clear improvement from the third day of administration. Even if it is not administered for more than a week, it is excellent in that the effect is sustained.
- Such effects are exceptional compared to conventional lactic acid bacteria tablets with an effective rate of about 60% and yogurt containing about 50% efficient and uncomfortable and uncomfortable lactic acid bacteria when used as a cleaning agent. It is an excellent one.
- the end point of treatment effect is 30 days, compared with lactic acid produced by lactic acid bacteria, the efficacy is excellent and there is a clear difference in the improvement of the skin surface.
- the soymilk fermented liquid or extract thereof which is an intravaginal cleaning agent of the present invention, has a therapeutic effect not inferior to the commercially available Kuguchimai vaginal tablet and has no side effects at all. .
- lactic acid bacteria fermentation broth extract a commercially available substance estimated to be produced or secreted by lactic acid bacteria (hereinafter referred to as lactic acid bacteria fermentation broth extract) is said to have an effect of improving the state of intestinal microorganisms. It is an excellent cleaning agent for the vagina of women suffering from bacterial vaginosis, Chlamydia vaginitis, Trichomonas vaginitis, Candida vaginitis, etc. It can be used widely in the fields of medicine, medicine, and pharmaceuticals.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Devices For Medical Bathing And Washing (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/523,721 US20060018984A1 (en) | 2002-08-07 | 2003-08-06 | Intravaginal washing agent |
AU2003252415A AU2003252415A1 (en) | 2002-08-07 | 2003-08-06 | Intravaginal washing agent |
EP03784536A EP1541162A1 (en) | 2002-08-07 | 2003-08-06 | Intravaginal washing agent |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002230034A JP2004067599A (ja) | 2002-08-07 | 2002-08-07 | 腟内洗浄剤 |
JP2002-230034 | 2002-08-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004014408A1 true WO2004014408A1 (ja) | 2004-02-19 |
Family
ID=31711671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/009989 WO2004014408A1 (ja) | 2002-08-07 | 2003-08-06 | 膣内洗浄剤 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20060018984A1 (ja) |
EP (1) | EP1541162A1 (ja) |
JP (1) | JP2004067599A (ja) |
AU (1) | AU2003252415A1 (ja) |
WO (1) | WO2004014408A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7668325B2 (en) * | 2005-05-03 | 2010-02-23 | Earlens Corporation | Hearing system having an open chamber for housing components and reducing the occlusion effect |
KR101568451B1 (ko) | 2008-06-17 | 2015-11-11 | 이어렌즈 코포레이션 | 결합된 전력 및 신호 구조를 갖는 광학 전기기계 듣기 장치 |
WO2011084616A2 (en) * | 2009-12-16 | 2011-07-14 | Macroplata, Inc. | Arrangements and methods for effecting an endoluminal anatomical structure |
WO2014106541A1 (en) * | 2013-01-04 | 2014-07-10 | Ellen Ab | Dermal composition for use in the external genital area in females |
JP5918290B2 (ja) * | 2014-03-19 | 2016-05-18 | 株式会社バイオジェノミクス | 乳酸菌生産物質の製造方法及び乳酸菌生産物質並びにアレルギー性皮膚炎抑制剤及び全身性アレルギー反応抑制剤 |
WO2018035036A1 (en) * | 2016-08-15 | 2018-02-22 | Earlens Corporation | Hearing aid connector |
RU2629592C1 (ru) * | 2016-09-29 | 2017-08-30 | Владимир Федорович Корсун | Средство для лечения хламидиоза |
CN106729247A (zh) * | 2017-02-18 | 2017-05-31 | 成都市飞龙水处理技术研究所青白江第分所 | 一种治疗妇女带下的中药组合物及其制备方法 |
EP3388063A1 (en) * | 2017-04-14 | 2018-10-17 | Adamed sp. z o.o. | Treatment of a bacterial vaginal infection |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08280369A (ja) * | 1995-04-18 | 1996-10-29 | Asama Kasei Kk | 食品用保存剤 |
WO1998046261A1 (en) * | 1997-04-11 | 1998-10-22 | Gynelogix, Inc. | Vaginal lactobacillus medicant |
JP2000125810A (ja) * | 1998-10-22 | 2000-05-09 | Yangu Kk | 炎症抑制作用及び感染症防御作用のある濃縮飲料 |
EP1082964A1 (en) * | 1998-06-05 | 2001-03-14 | Wakamoto Pharmaceutical Co., Ltd. | Lactic acid bacterium-containing compositions, drugs and foods |
WO2001034168A1 (en) * | 1999-11-08 | 2001-05-17 | Ganeden Biotech, Inc. | Inhibition of pathogens by bacillus coagulans strains |
JP2001158743A (ja) * | 1999-12-02 | 2001-06-12 | Wakamoto Pharmaceut Co Ltd | 乳酸菌含有組成物、医薬及び食品 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69802260T2 (de) * | 1998-04-30 | 2002-07-04 | Renata Maria Anna Cavaliere Vesely | Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen |
ATE334725T1 (de) * | 1998-10-09 | 2006-08-15 | Yakult Honsha Kk | Hautpflegezubereitungen zur äusseren anwendung |
JP4193330B2 (ja) * | 2000-05-24 | 2008-12-10 | ビーエイチピーエイチ カンパニーリミテッド | 新規な感染症対応型乳酸菌および該乳酸菌を主成分とした乳酸菌製剤 |
JP4612180B2 (ja) * | 2000-12-19 | 2011-01-12 | 株式会社ヤクルト本社 | 皮膚外用剤 |
-
2002
- 2002-08-07 JP JP2002230034A patent/JP2004067599A/ja active Pending
-
2003
- 2003-08-06 WO PCT/JP2003/009989 patent/WO2004014408A1/ja active Application Filing
- 2003-08-06 EP EP03784536A patent/EP1541162A1/en not_active Withdrawn
- 2003-08-06 US US10/523,721 patent/US20060018984A1/en not_active Abandoned
- 2003-08-06 AU AU2003252415A patent/AU2003252415A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08280369A (ja) * | 1995-04-18 | 1996-10-29 | Asama Kasei Kk | 食品用保存剤 |
WO1998046261A1 (en) * | 1997-04-11 | 1998-10-22 | Gynelogix, Inc. | Vaginal lactobacillus medicant |
EP1082964A1 (en) * | 1998-06-05 | 2001-03-14 | Wakamoto Pharmaceutical Co., Ltd. | Lactic acid bacterium-containing compositions, drugs and foods |
JP2000125810A (ja) * | 1998-10-22 | 2000-05-09 | Yangu Kk | 炎症抑制作用及び感染症防御作用のある濃縮飲料 |
WO2001034168A1 (en) * | 1999-11-08 | 2001-05-17 | Ganeden Biotech, Inc. | Inhibition of pathogens by bacillus coagulans strains |
JP2001158743A (ja) * | 1999-12-02 | 2001-06-12 | Wakamoto Pharmaceut Co Ltd | 乳酸菌含有組成物、医薬及び食品 |
Non-Patent Citations (2)
Title |
---|
REID G. ET AL.: "Probiotic lactobacillus dose required and maintain a normal vagina flora", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, vol. 32, no. 1, 2001, pages 37 - 41, XP002973521 * |
WOOD JANICE R. ET AL.: "In vitro adherence of lactobacillus species to vaginal epithelial cells", AMERICAN J. OBSTETRICS AND GYNECOLOGY, vol. 153, no. 7, 1985, pages 740 - 743, XP000929218 * |
Also Published As
Publication number | Publication date |
---|---|
US20060018984A1 (en) | 2006-01-26 |
JP2004067599A (ja) | 2004-03-04 |
EP1541162A1 (en) | 2005-06-15 |
AU2003252415A1 (en) | 2004-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101885403B1 (ko) | 신규 락트산 박테리아 및 그를 함유하는 조성물 | |
EP1911454B1 (en) | A composition and method of regulating and maintaining the vaginal bacterial flora and the normal acidity in the vagina | |
KR101808972B1 (ko) | 락토바실러스 크리스파투스 및 이의 사용 | |
CN107815432B (zh) | 一种人用灭活乳酸菌制剂及其用途 | |
CN1888051B (zh) | 一株植物乳杆菌及其应用 | |
EP3233098B1 (en) | Cvs transplantation for treatment of bacterial vaginosis | |
Tester et al. | The use of konjac glucomannan hydrolysates to recover healthy microbiota in infected vaginas treated with an antifungal agent | |
KR20210114436A (ko) | 로도코커스 루버로부터 유래하는 생성물 및 이의 약학 용도 | |
US11000558B2 (en) | Vaginal preparations for maintaining and/or restoring healthy female microbiota | |
WO2011041938A1 (zh) | 一种以苯甲酸和有机酸防腐剂相联合作为有效成分的组合物及其用途 | |
WO2015135470A1 (zh) | 一种阴道用组合物与该组合物的用途 | |
CN111518714A (zh) | 一株能够预防和/或治疗念珠菌阴道炎的卷曲乳杆菌 | |
WO2004014408A1 (ja) | 膣内洗浄剤 | |
CN113278548B (zh) | 卷曲乳杆菌及在生产改善人体阴道环境的产品中的应用 | |
CN103157095A (zh) | 芸豆植物凝集素在制备人用药物中的应用及其药物组合物 | |
US20040022775A1 (en) | Methods of treating viral infections in mammals | |
CN101134052A (zh) | 酪酸梭菌、凝结芽孢杆菌、双歧杆菌在制备防治口腔溃疡药物中的应用 | |
EP3941499A1 (en) | A composition for competitive inhibition of pathogens and restoration of microbial ecological balance | |
Påhlson et al. | The ecologically wrong vaginal lactobacilli | |
CN113512509B (zh) | 卷曲乳杆菌及其用途 | |
CN112057601B (zh) | 一种活性益生菌冻干粉制备方法及在皮肤和妇科疾病中的应用 | |
CN112402463A (zh) | 一种用于抑制阴道炎症的复合益生菌及其制品和应用 | |
US20220233618A1 (en) | Composition containing a yeast for preventing simple and/or recurring cystitis | |
KR102679284B1 (ko) | 여성 질염 또는 질 건강 개선에 도움을 줄 수 있는 락토바실러스 플란타륨 yc-225가 포함된 프로바이오틱스 복합 조성물 | |
TW201121580A (en) | Vaginal cleaner and manufacture method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003784536 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006018984 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10523721 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2003784536 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10523721 Country of ref document: US |